Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
The global Microphysiological System market size is projected to grow from US$ 144 million in 2024 to US$ 743 million in 2030; it is expected to grow at a CAGR of 31.4% from 2024 to 2030.
The 鈥淢icrophysiological System Industry Forecast鈥� looks at past sales and reviews total world Microphysiological System sales in 2022, providing a comprehensive analysis by region and market sector of projected Microphysiological System sales for 2023 through 2029. With Microphysiological System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microphysiological System industry.
This Insight Report provides a comprehensive analysis of the global Microphysiological System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Microphysiological System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Microphysiological System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microphysiological System and breaks down the forecast by Type, by End User, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microphysiological System.
Global key players of Microphysiological System include Emulate, Mimetas, InSphero, CN Bio, etc. The top four players hold a share over 44%. North America is the largest market, with a share about 44%, followed by Europe and Asia-Pacific, with share 42% and 11%, separately. In terms of product type, Human Organ and Tissue Models is the largest segment, occupied for a share of 61%.
This report presents a comprehensive overview, market shares, and growth opportunities of Microphysiological System market by product type, application, key players and key regions and countries.
Segmentation by Type:
Human Organ and Tissue Models
Disease Models
Non-Human Species Models
Segmentation by End User:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Human Organ and Tissue Models
Disease Models
Non-Human Species Models
Segmentation by End User:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Emulate
Mimetas
InSphero
TissUse
CN Bio
Valo Health (TARA Biosystems)
Hesperos
TNO
AxoSim
Newcells Biotech
Nortis
Netri
Draper Laboratory
Beijing Daxiang Biotech
Altis Biosystems
Cherry Biotech
Bi/ond
Obatala Sciences
Ananda Devices
ImmuONE
React4life
AlveoliX
BiomimX
Aracari Bio
StemPharm
SynVivo
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Microphysiological System Market Size 2019-2030
2.1.2 Microphysiological System Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Microphysiological System by Country/Region, 2019, 2023 & 2030
2.2 Microphysiological System Segment by Type
2.2.1 Human Organ and Tissue Models
2.2.2 Disease Models
2.2.3 Non-Human Species Models
2.3 Microphysiological System Market Size by Type
2.3.1 Microphysiological System Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Microphysiological System Market Size Market Share by Type (2019-2024)
2.4 Microphysiological System Segment by End User
2.4.1 Pharmaceutical & Biotechnology Companies
2.4.2 Academic & Research Institutes
2.4.3 Others
2.5 Microphysiological System Market Size by End User
2.5.1 Microphysiological System Market Size CAGR by End User (2019 VS 2023 VS 2030)
2.5.2 Global Microphysiological System Market Size Market Share by End User (2019-2024)
3 Microphysiological System Market Size by Player
3.1 Microphysiological System Market Size Market Share by Player
3.1.1 Global Microphysiological System Revenue by Player (2019-2024)
3.1.2 Global Microphysiological System Revenue Market Share by Player (2019-2024)
3.2 Global Microphysiological System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Microphysiological System by Region
4.1 Microphysiological System Market Size by Region (2019-2024)
4.2 Global Microphysiological System Annual Revenue by Country/Region (2019-2024)
4.3 Americas Microphysiological System Market Size Growth (2019-2024)
4.4 APAC Microphysiological System Market Size Growth (2019-2024)
4.5 Europe Microphysiological System Market Size Growth (2019-2024)
4.6 Middle East & Africa Microphysiological System Market Size Growth (2019-2024)
5 Americas
5.1 Americas Microphysiological System Market Size by Country (2019-2024)
5.2 Americas Microphysiological System Market Size by Type (2019-2024)
5.3 Americas Microphysiological System Market Size by End User (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microphysiological System Market Size by Region (2019-2024)
6.2 APAC Microphysiological System Market Size by Type (2019-2024)
6.3 APAC Microphysiological System Market Size by End User (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Microphysiological System Market Size by Country (2019-2024)
7.2 Europe Microphysiological System Market Size by Type (2019-2024)
7.3 Europe Microphysiological System Market Size by End User (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Microphysiological System by Region (2019-2024)
8.2 Middle East & Africa Microphysiological System Market Size by Type (2019-2024)
8.3 Middle East & Africa Microphysiological System Market Size by End User (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Microphysiological System Market Forecast
10.1 Global Microphysiological System Forecast by Region (2025-2030)
10.1.1 Global Microphysiological System Forecast by Region (2025-2030)
10.1.2 Americas Microphysiological System Forecast
10.1.3 APAC Microphysiological System Forecast
10.1.4 Europe Microphysiological System Forecast
10.1.5 Middle East & Africa Microphysiological System Forecast
10.2 Americas Microphysiological System Forecast by Country (2025-2030)
10.2.1 United States Market Microphysiological System Forecast
10.2.2 Canada Market Microphysiological System Forecast
10.2.3 Mexico Market Microphysiological System Forecast
10.2.4 Brazil Market Microphysiological System Forecast
10.3 APAC Microphysiological System Forecast by Region (2025-2030)
10.3.1 China Microphysiological System Market Forecast
10.3.2 Japan Market Microphysiological System Forecast
10.3.3 Korea Market Microphysiological System Forecast
10.3.4 Southeast Asia Market Microphysiological System Forecast
10.3.5 India Market Microphysiological System Forecast
10.3.6 Australia Market Microphysiological System Forecast
10.4 Europe Microphysiological System Forecast by Country (2025-2030)
10.4.1 Germany Market Microphysiological System Forecast
10.4.2 France Market Microphysiological System Forecast
10.4.3 UK Market Microphysiological System Forecast
10.4.4 Italy Market Microphysiological System Forecast
10.4.5 Russia Market Microphysiological System Forecast
10.5 Middle East & Africa Microphysiological System Forecast by Region (2025-2030)
10.5.1 Egypt Market Microphysiological System Forecast
10.5.2 South Africa Market Microphysiological System Forecast
10.5.3 Israel Market Microphysiological System Forecast
10.5.4 Turkey Market Microphysiological System Forecast
10.6 Global Microphysiological System Forecast by Type (2025-2030)
10.7 Global Microphysiological System Forecast by End User (2025-2030)
10.7.1 GCC Countries Market Microphysiological System Forecast
11 Key Players Analysis
11.1 Emulate
11.1.1 Emulate Company Information
11.1.2 Emulate Microphysiological System Product Offered
11.1.3 Emulate Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Emulate Main Business Overview
11.1.5 Emulate Latest Developments
11.2 Mimetas
11.2.1 Mimetas Company Information
11.2.2 Mimetas Microphysiological System Product Offered
11.2.3 Mimetas Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Mimetas Main Business Overview
11.2.5 Mimetas Latest Developments
11.3 InSphero
11.3.1 InSphero Company Information
11.3.2 InSphero Microphysiological System Product Offered
11.3.3 InSphero Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 InSphero Main Business Overview
11.3.5 InSphero Latest Developments
11.4 TissUse
11.4.1 TissUse Company Information
11.4.2 TissUse Microphysiological System Product Offered
11.4.3 TissUse Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 TissUse Main Business Overview
11.4.5 TissUse Latest Developments
11.5 CN Bio
11.5.1 CN Bio Company Information
11.5.2 CN Bio Microphysiological System Product Offered
11.5.3 CN Bio Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 CN Bio Main Business Overview
11.5.5 CN Bio Latest Developments
11.6 Valo Health (TARA Biosystems)
11.6.1 Valo Health (TARA Biosystems) Company Information
11.6.2 Valo Health (TARA Biosystems) Microphysiological System Product Offered
11.6.3 Valo Health (TARA Biosystems) Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Valo Health (TARA Biosystems) Main Business Overview
11.6.5 Valo Health (TARA Biosystems) Latest Developments
11.7 Hesperos
11.7.1 Hesperos Company Information
11.7.2 Hesperos Microphysiological System Product Offered
11.7.3 Hesperos Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Hesperos Main Business Overview
11.7.5 Hesperos Latest Developments
11.8 TNO
11.8.1 TNO Company Information
11.8.2 TNO Microphysiological System Product Offered
11.8.3 TNO Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 TNO Main Business Overview
11.8.5 TNO Latest Developments
11.9 AxoSim
11.9.1 AxoSim Company Information
11.9.2 AxoSim Microphysiological System Product Offered
11.9.3 AxoSim Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 AxoSim Main Business Overview
11.9.5 AxoSim Latest Developments
11.10 Newcells Biotech
11.10.1 Newcells Biotech Company Information
11.10.2 Newcells Biotech Microphysiological System Product Offered
11.10.3 Newcells Biotech Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Newcells Biotech Main Business Overview
11.10.5 Newcells Biotech Latest Developments
11.11 Nortis
11.11.1 Nortis Company Information
11.11.2 Nortis Microphysiological System Product Offered
11.11.3 Nortis Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Nortis Main Business Overview
11.11.5 Nortis Latest Developments
11.12 Netri
11.12.1 Netri Company Information
11.12.2 Netri Microphysiological System Product Offered
11.12.3 Netri Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Netri Main Business Overview
11.12.5 Netri Latest Developments
11.13 Draper Laboratory
11.13.1 Draper Laboratory Company Information
11.13.2 Draper Laboratory Microphysiological System Product Offered
11.13.3 Draper Laboratory Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Draper Laboratory Main Business Overview
11.13.5 Draper Laboratory Latest Developments
11.14 Beijing Daxiang Biotech
11.14.1 Beijing Daxiang Biotech Company Information
11.14.2 Beijing Daxiang Biotech Microphysiological System Product Offered
11.14.3 Beijing Daxiang Biotech Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Beijing Daxiang Biotech Main Business Overview
11.14.5 Beijing Daxiang Biotech Latest Developments
11.15 Altis Biosystems
11.15.1 Altis Biosystems Company Information
11.15.2 Altis Biosystems Microphysiological System Product Offered
11.15.3 Altis Biosystems Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Altis Biosystems Main Business Overview
11.15.5 Altis Biosystems Latest Developments
11.16 Cherry Biotech
11.16.1 Cherry Biotech Company Information
11.16.2 Cherry Biotech Microphysiological System Product Offered
11.16.3 Cherry Biotech Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Cherry Biotech Main Business Overview
11.16.5 Cherry Biotech Latest Developments
11.17 Bi/ond
11.17.1 Bi/ond Company Information
11.17.2 Bi/ond Microphysiological System Product Offered
11.17.3 Bi/ond Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Bi/ond Main Business Overview
11.17.5 Bi/ond Latest Developments
11.18 Obatala Sciences
11.18.1 Obatala Sciences Company Information
11.18.2 Obatala Sciences Microphysiological System Product Offered
11.18.3 Obatala Sciences Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Obatala Sciences Main Business Overview
11.18.5 Obatala Sciences Latest Developments
11.19 Ananda Devices
11.19.1 Ananda Devices Company Information
11.19.2 Ananda Devices Microphysiological System Product Offered
11.19.3 Ananda Devices Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Ananda Devices Main Business Overview
11.19.5 Ananda Devices Latest Developments
11.20 ImmuONE
11.20.1 ImmuONE Company Information
11.20.2 ImmuONE Microphysiological System Product Offered
11.20.3 ImmuONE Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 ImmuONE Main Business Overview
11.20.5 ImmuONE Latest Developments
11.21 React4life
11.21.1 React4life Company Information
11.21.2 React4life Microphysiological System Product Offered
11.21.3 React4life Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 React4life Main Business Overview
11.21.5 React4life Latest Developments
11.22 AlveoliX
11.22.1 AlveoliX Company Information
11.22.2 AlveoliX Microphysiological System Product Offered
11.22.3 AlveoliX Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 AlveoliX Main Business Overview
11.22.5 AlveoliX Latest Developments
11.23 BiomimX
11.23.1 BiomimX Company Information
11.23.2 BiomimX Microphysiological System Product Offered
11.23.3 BiomimX Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 BiomimX Main Business Overview
11.23.5 BiomimX Latest Developments
11.24 Aracari Bio
11.24.1 Aracari Bio Company Information
11.24.2 Aracari Bio Microphysiological System Product Offered
11.24.3 Aracari Bio Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 Aracari Bio Main Business Overview
11.24.5 Aracari Bio Latest Developments
11.25 StemPharm
11.25.1 StemPharm Company Information
11.25.2 StemPharm Microphysiological System Product Offered
11.25.3 StemPharm Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 StemPharm Main Business Overview
11.25.5 StemPharm Latest Developments
11.26 SynVivo
11.26.1 SynVivo Company Information
11.26.2 SynVivo Microphysiological System Product Offered
11.26.3 SynVivo Microphysiological System Revenue, Gross Margin and Market Share (2019-2024)
11.26.4 SynVivo Main Business Overview
11.26.5 SynVivo Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.